Guest
Nupsala invited Equicord’s chief scientific officer Almudena Pradera-Munoz to speak about Horstem. Almudena is a Veterinary surgeon and holds a PhD in physiology and pharmacology. Horstem is the only licensed equine MSC and is indicated for the reduction of lameness associated with mild to moderate degenerative joint disease (osteoarthritis) in horses. This webinar covers all aspects of what makes Horstem unique, from how the stem cells are harvested, to an in-depth explanation of the mechanism of action once injected. Almudena also discusses indications for use and how it has been developed in a ‘ready-to-use’ format.
